Stocks on the Move: Gilead Sciences on FDA rejection of their drug application, BioMarin Pharmaceutical on the FDA rejection of their hemophilia A gene therapy

Yahoo Finance’s On the Move panel discuss today’s Stocks on the Move: Gilead Sciences and Biomarin Pharmaceutical